Cantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

Benzinga · 1d ago
Cantor Fitzgerald analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $27 to $28.